Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Derived neutrophil-to-lymphocyte ratio (dNLR) is an emerging blood-based inflammatory biomarker previously reported to have prognostic value in various malignancies. This study aimed to investigate the prognostic significance of dNLR in patients with distal cholangiocarcinoma (dCCA) after curative resection.

Methods: Clinicopathological data of patients with dCCA in our hospital from Jan.2014 to Jun.2024 was analyzed retrospectively. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive value of dNLR and to identify the optimal cutoff. Survival differences between groups stratified by dNLR were compared using Kaplan-Meier analysis. Candidate variables were screened through univariate analysis using Kaplan-Meier, random forest, Recursive Feature Elimination (RFE) and least absolute shrinkage and selection operator (LASSO) regression models. Multivariate Cox regression analysis identified independent prognostic factors, which were subsequently integrated into a predictive model visualized via a nomogram. Model performance was assessed using ROC curves, calibration curves, and decision curve analysis (DCA).

Results: A total of 177 patients were enrolled in this study. ROC analysis revealed an area under the curve (AUC) of 0.707 for dNLR in predicting postoperative survival, with an optimal cutoff value of 1.60. Patients stratified into a low-dNLR group (≤ 1.60) demonstrated significantly improved recurrence-free survival (41 months) and overall survival (17 months) compared to those in the high-dNLR group (> 1.60) ( < 0.05). Univariate and multivariate combined with 3 machine learning analyses identified preoperative dNLR > 1.60 as an independent adverse prognostic factor for postoperative outcomes, incorporating with other independent predictors (preoperative total bilirubin, carbohydrate antigen 19-9 levels, T-stage, portal venous system invasion, and lymph node metastasis) further enhanced the predictive accuracy of the prognostic model.

Conclusion: A preoperative dNLR > 1.60 is an independent risk factor associated with poor prognosis in patients with dCCA. The clinical prediction model based on machine learning incorporating dNLR effectively predicts postoperative outcomes in this patient population.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12318768PMC
http://dx.doi.org/10.3389/fonc.2025.1625703DOI Listing

Publication Analysis

Top Keywords

distal cholangiocarcinoma
8
dnlr
8
patients dcca
8
curve analysis
8
optimal cutoff
8
survival months
8
machine learning
8
preoperative dnlr
8
dnlr 160
8
160 independent
8

Similar Publications

The role of adjuvant therapy (AT) after pancreaticoduodenectomy (PD) for distal cholangiocarcinoma (DC) remains controversial. This systematic review and meta-analysis aimed to evaluate the impact of AT on overall survival (OS) and disease-free survival (DFS) in patients with resected DC. A systematic review was conducted following PRISMA guidelines (PROSPERO: CRD42024561780).

View Article and Find Full Text PDF

We report a case of obstructive jaundice due to recurrent distal biliary stricture during 3 years of treatment for immunoglobulin G4 (IgG4)-related sclerosing cholangitis (IgG4-SC) associated with autoimmune pancreatitis. Although a relapse of IgG4-SC was initially suspected, imaging findings, laboratory tests, and histopathological examinations led to the diagnosis of metachronous cholangiocarcinoma. The patient underwent pancreaticoduodenectomy, and no cancer recurrence was noted 6 months postoperatively.

View Article and Find Full Text PDF

Background/aim: Cholangiocarcinoma (CCA) is the second most frequently occurring primary malignant tumor of the liver, characterized by poor survival due to late diagnosis and limited treatment options. The albumin-bilirubin (ALBI) and platelet-ALBI (PALBI) scores, which reflect liver function and inflammation, have emerged as potential prognostic markers in hepatocellular carcinoma (HCC). Their prognostic significance in CCA, however, remains less established.

View Article and Find Full Text PDF

: The TOPAZ-1 phase III trial reported a survival benefit of using durvalumab, an anti-programmed death ligand 1 (anti-PD-L1) antibody, in combination with gemcitabine and cisplatin (GCD) treatment in patients with advanced biliary tract cancer. This retrospective study investigated the efficacy and safety of GCD treatment for advanced biliary tract cancer in real-world conditions. : The study subjects were 52 patients with biliary tract cancer who received GCD therapy between January 2023 and May 2024.

View Article and Find Full Text PDF

The majority (70-85%) of biliary strictures-a narrowing of the bile ducts-are associated with malignancy, particularly pancreatic adenocarcinoma and cholangiocarcinoma, and are unresectable at presentation. Management options for distal biliary obstruction depend on several clinical factors, including the underlying cause and the location and complexity of the stricture. Endoscopic stent placement has lower morbidity and mortality rates compared with more invasive surgical options and is usually the first-line treatment to clear the blockage or allow the bile duct to drain internally.

View Article and Find Full Text PDF